BlackRock
PFE icon

BlackRock’s Pfizer PFE Stock Holding History

BlackRock’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,244,500
Closed -$64.6M – 5363
2023
Q4 		$64.6M Hold
2,244,500
– – ﹤0.01% 2321
2023
Q3 		$74.5M Sell
2,244,500
-1,842,500
-45% -$65.2M ﹤0.01% 2162
2023
Q2 		$150M Buy
+4,087,000
New +$159M ﹤0.01% 1788
2022
Q2 		– Sell
-602,800
Closed -$31.2M – 5951
2022
Q1 		$31.2M Buy
+602,800
New +$31.3M ﹤0.01% 2887
2019
Q3 		– Sell
-2,845,589
Closed -$117M – 5051
2019
Q2 		$117M Buy
+2,845,589
New +$113M 0.01% 1801

Other funds holding PFE

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BlackRock's PFE Position: Q2 2026 in Review

BlackRock increased its Pfizer (PFE) stake by 6.3% in Q2 2026, buying an estimated $822M and bringing the position to 529,670,433 shares worth $12.8B. The position accounts for 0.19% of the portfolio, ranked #79.

BlackRock first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $24.2B in Q4 2021. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • BlackRock held 529,670,433 shares of Pfizer worth $12.8B as of Q2 2026.
  • BlackRock bought 31,412,883 Pfizer shares in Q2 2026, an estimated $822M.
  • Pfizer made up 0.19% of BlackRock's portfolio in Q2 2026, its #79 holding.
  • BlackRock first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • BlackRock's Pfizer position peaked at $24.2B in Q4 2021.
  • 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.